To determine the number of muscle invasive bladder cancer patients who could potentially benefit from an inhibitor of eIF4E phosphorylation, we conducted phospho-eIF4E S209 IHC of human urothelial carcinoma tissue specimens. Here, EIF4E is linked to urothelial carcinoma.